Literature DB >> 35928180

Immunological and functional features of decellularized xenogeneic heart valves after transplantation into GGTA1-KO pigs.

Robert Ramm1, Tobias Goecke1,2, Peter Köhler3, Igor Tudorache2, Serghei Cebotari2, Anatol Ciubotaru2, Samir Sarikouch2, Klaus Höffler2, Friederike Bothe4, Björn Petersen3, Axel Haverich1,2, Heiner Niemann3, Andres Hilfiker1,2.   

Abstract

Decellularization of xenogeneic heart valves might lead to excellent regenerative implants, from which many patients could benefit. However, this material carries various xenogeneic epitopes and thus bears a considerable inherent immunological risk. Here, we investigated the regenerative and immunogenic potential of xenogeneic decellularized heart valve implants using pigs deficient for the galactosyltransferase gene (GGTA1-KO) as novel large animal model. Decellularized aortic and pulmonary heart valves obtained from sheep, wild-type pigs or GGTA1-KO pigs were implanted into GGTA1-KO pigs for 3, or 6 months, respectively. Explants were analyzed histologically, immunhistologically (CD3, CD21 and CD172a) and anti-αGal antibody serum titers were determined by ELISA. Xenogeneic sheep derived implants exhibited a strong immune reaction upon implantation into GGTA1-KO pigs, characterized by massive inflammatory cells infiltrates, presence of foreign body giant cells, a dramatic increase of anti-αGal antibody titers and ultimately destruction of the graft, whereas wild-type porcine grafts induced only a mild reaction in GGTA1-KO pigs. Allogeneic implants, wild-type/wild-type and GGTA1-KO/GGTA1-KO valves did not induce a measurable immune reaction. Thus, GGTA1-KO pigs developed a 'human-like' immune response toward decellularized xenogeneic implants showing that immunogenicity of xenogeneic implants is not sufficiently reduced by decellularization, which detracts from their regenerative potential. © Crown copyright 2021.

Entities:  

Keywords:  decellularization; heart valves; large animal model; xenoantibodies; αGal-KO pig

Year:  2021        PMID: 35928180      PMCID: PMC8329474          DOI: 10.1093/rb/rbab036

Source DB:  PubMed          Journal:  Regen Biomater        ISSN: 2056-3426


  33 in total

1.  Xenotransplantation makes a comeback.

Authors:  Jeffrey M Perkel
Journal:  Nat Biotechnol       Date:  2016-01       Impact factor: 54.908

2.  Toward acellular xenogeneic heart valve prostheses: Histological and biomechanical characterization of decellularized and enzymatically deglycosylated porcine pulmonary heart valve matrices.

Authors:  Katja Findeisen; Lucrezia Morticelli; Tobias Goecke; Louisa Kolbeck; Robert Ramm; Hans-Klaus Höffler; Gudrun Brandes; Sotirios Korossis; Axel Haverich; Andres Hilfiker
Journal:  Xenotransplantation       Date:  2020-06-18       Impact factor: 3.907

3.  Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes.

Authors:  Jose L Estrada; Greg Martens; Ping Li; Andrew Adams; Kenneth A Newell; Mandy L Ford; James R Butler; Richard Sidner; Matt Tector; Joseph Tector
Journal:  Xenotransplantation       Date:  2015-03-01       Impact factor: 3.907

4.  Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue.

Authors:  R W Farndale; D J Buttle; A J Barrett
Journal:  Biochim Biophys Acta       Date:  1986-09-04

5.  Early failure of xenogenous de-cellularised pulmonary valve conduits--a word of caution!

Authors:  André Rüffer; Ariawan Purbojo; Iwona Cicha; Martin Glöckler; Sergej Potapov; Sven Dittrich; Robert Anton Cesnjevar
Journal:  Eur J Cardiothorac Surg       Date:  2010-03-12       Impact factor: 4.191

6.  The pathology of solid organ xenotransplantation.

Authors:  Ivy A Rosales; Robert B Colvin
Journal:  Curr Opin Organ Transplant       Date:  2019-10       Impact factor: 2.640

Review 7.  Semi-xenotransplantation: the regenerative medicine-based approach to immunosuppression-free transplantation and to meet the organ demand.

Authors:  Marcus Salvatori; Andrea Peloso; Ravi Katari; Shay Soker; Jan P Lerut; Robert J Stratta; Giuseppe Orlando
Journal:  Xenotransplantation       Date:  2014-07-08       Impact factor: 3.907

8.  * Six-Year-Old Sheep as a Clinically Relevant Large Animal Model for Aortic Valve Replacement Using Tissue-Engineered Grafts Based on Decellularized Allogenic Matrix.

Authors:  Karolina Theodoridis; Igor Tudorache; Serghei Cebotari; Alexandru Calistru; Tanja Meyer; Samir Sarikouch; Christoph Bara; Axel Haverich; Andres Hilfiker
Journal:  Tissue Eng Part C Methods       Date:  2017-11-03       Impact factor: 3.056

9.  No evidence for αGal epitope transfer from media containing FCS onto human endothelial cells in culture.

Authors:  Robert Ramm; Thorsten Hartmann; Igor Tudorache; Axel Haverich; Andres Hilfiker
Journal:  Xenotransplantation       Date:  2015-08-24       Impact factor: 3.907

10.  IgG deposition and activation of the classical complement pathway involvement in the activation of human granulocytes by decellularized porcine heart valve tissue.

Authors:  Fabienne Bastian; Marie-Elisabeth Stelzmüller; Klaus Kratochwill; Marie-Theres Kasimir; Paul Simon; Guenter Weigel
Journal:  Biomaterials       Date:  2008-02-07       Impact factor: 12.479

View more
  1 in total

1.  Serial assessment of early antibody binding to decellularized valved allografts.

Authors:  Firdavs Oripov; Robert Ramm; Christine Falk; Tobias Goecke; Johannes Ebken; Ramadan Jashari; Dietmar Böthig; Alexander Horke; Murat Avsar; Dmitry Bobylev; Axel Haverich; Andres Hilfiker; Samir Sarikouch
Journal:  Front Cardiovasc Med       Date:  2022-08-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.